SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-310805
Filing Date
2020-12-07
Accepted
2020-12-04 18:14:05
Documents
5

Document Format Files

Seq Description Document Type Size
1 S-3 d62883ds3.htm S-3 315292
2 EX-5.1 d62883dex51.htm EX-5.1 33095
3 EX-23.1 d62883dex231.htm EX-23.1 2050
4 GRAPHIC g62883dsp3.jpg GRAPHIC 2708
5 GRAPHIC g62883gibson_dunn.jpg GRAPHIC 6434
  Complete submission text file 0001193125-20-310805.txt   364395
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-251161 | Film No.: 201370932
SIC: 2834 Pharmaceutical Preparations